Atlas Trials

A Comparative Study to Evaluate the Effects and Mechanism of Action of Dysport®, Botox® and Xeomin® in the Extensor Digitorum Brevis Model in Healthy Adult Male Participants

Clinical trial NCT04970407 · COMPLETED

Trial details

NCT number
NCT04970407
Sponsor
Ipsen
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Participants
Start date
2021-07-06
Primary completion
2022-03-16
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.